According to the in vitro results, we reported that FGFR4-388Gly overexpression in these xenografts caused decreased tumor growth in the H2009 cell line, and increased tumor growth in the H226 cell line, as compared to their respective control cell lines. This evidence concerns the gene FGFR4 and neoplasm.